Am-Pharma B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Am-Pharma B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                         Am-Pharma B.V. - Pharmaceuticals & Healthcare - Deals and Alliances
                                                      Profile
       Reference Code: GDPH126537D                                                                                                              Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      AM-Pharma B.V. (AM-Pharma) a biopharmaceutical company. The company
                                                                                                              Am-Pharma B.V., Pharmaceuticals & Healthcare,
      develops human alkaline phosphatase therapeutics for various inflammatory
                                                                                                              Key Facts
      diseases. Its products include acute kidney injury kits and inflammatory bowel
      disease kits. The company’s human form of alkaline phosphatase is stable and                             Web Address                            www.am-pharma.com
      active, and has been optimized for treating inflammatory conditions. It develops
                                                                                                               Revenue (US$ million)                                 NA
      products based on endogenous proteins and protein derived peptides, as well as
      molecules that naturally occur in the human body. The company’s phase I and                              Number of Employees                                   NA
      phase II clinical trials of Alkaline Phosphatase operates as an oral therapy for                         GlobalData
      Ulcerative Colitis. AM-Pharma is headquartered in Bunnik, the Netherlands.

      Financial Deals Landscape
        Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals by Type,                      Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013


                                                                                                                 1         1                          1
                                                                                                          1


                                                                                           No. of Deals



                                                                                                                                   0        0              0          0
                                                                                                          0
                                                                                                               2007       2008    2009     2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals By                           Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013


                                3
                                                                                           No. of De…




                         3                                                                                3
                                                                                                                      3                3          3
          No. of Deals




                                                                                                          2
                                                                                                                                                                 1
                         2
                                                                                                          1

                         1                                                                                0
                                                                                                                 Gastroint        Genito  Infectiou       Immunol
                                          0           0            0                                              estinal         Urinary s Disease         ogy
                         0                                                                                                        System
                              Europe   Asia-       Middle       North                                                            And Sex
                                       Pacific    East and     America                                                           Hormone
                                                   Africa                                                                            s



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Am-Pharma B.V. - Pharmaceuticals & Healthcare - Deals and                                                                                         Reference Code: GDPH126537D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013....................................................................... 4
       Am-Pharma B.V., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ....................................................................... 5
       Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ................................................................... 6
       Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013......................................................... 7
       Am-Pharma B.V., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .................................................................... 8
       Am-Pharma B.V., Pharmaceuticals & Healthcare, Deal Details ......................................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             AM-Pharma Secures $39.7 Million In Series D Financing ........................................................................................................... 9
             AM-Pharma Completes First Close Of $11.03 Million In Series C Financing Round ................................................................ 12
             AM-Pharma Secures $3.42 Million In Venture Financing .......................................................................................................... 14
       Am-Pharma B.V. - Key Competitors ................................................................................................................................................. 15
       Key Employees ................................................................................................................................................................................ 16
       Locations And Subsidiaries .............................................................................................................................................................. 17
          Head Office ................................................................................................................................................................................... 17
       Recent Developments ...................................................................................................................................................................... 18
          Corporate Communications .......................................................................................................................................................... 18
             Jan 04, 2012: AM-Pharma Appoints Russell Greig As Chairman .........................................................
				
DOCUMENT INFO
Description: AM-Pharma B.V. (AM-Pharma) a biopharmaceutical company. The company develops human alkaline phosphatase therapeutics for various inflammatory diseases. Its products include acute kidney injury kits and inflammatory bowel disease kits. The company’s human form of alkaline phosphatase is stable and active, and has been optimized for treating inflammatory conditions. It develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. The company’s phase I and phase II clinical trials of Alkaline Phosphatase operates as an oral therapy for Ulcerative Colitis. AM-Pharma is headquartered in Bunnik, the Netherlands.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.